Future Medicines Institute partners with LYVA Labs for national programme to accelerate future medicines development

The Innovate UK Biomedical Catalyst Accelerator Future Medicines is now open for applications!

We’re proud to be a partner on this national programme led by LYVA Labs and Innovate UK, supporting UK innovators developing the next generation of medical treatments and technologies.

The programme is designed for early-stage companies (TRL2-4) working on transformative innovations in future medicines - with radiopharmaceuticals identified as a priority area.

Over six months, participants will gain access to:

·         Expertise in drug discovery, development, and regulation

·         Market research, commercial strategy & investor readiness support

·         Fully funded technical roadmap development

·         Access to sector experts, facilities & peer-to-peer networks

·         Face-to-face peer and investor event

Applications are open 1st - 26th September 2025.

Learn more:       https://lyvalabs.com/future-medicines

Apply here:        https://lyvalabs.com/future-medicines-apply

For more information, email: futuremedicines.accelerator@lyvalabs.com

This Accelerator is funded by Innovate UK Biomedical Catalyst. Innovate UK is creating a better future by inspiring, involving and investing in businesses developing life-changing innovations.